{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:20:56Z","timestamp":1794230456833,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373337"],"award-info":[{"award-number":["82373337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070785"],"award-info":[{"award-number":["82070785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303760"],"award-info":[{"award-number":["82303760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Province Young Talents Program","award":["2023RC3073, 2021RC3027"],"award-info":[{"award-number":["2023RC3073, 2021RC3027"]}]},{"name":"Hunan Province Young Talents Program","award":["2023RC3073, 2021RC3027"],"award-info":[{"award-number":["2023RC3073, 2021RC3027"]}]},{"name":"Hunan Provincial Key Area Research Plan","award":["2023SK2016"],"award-info":[{"award-number":["2023SK2016"]}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20230431"],"award-info":[{"award-number":["BX20230431"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M733951"],"award-info":[{"award-number":["2023M733951"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40946, 2024JJ2093"],"award-info":[{"award-number":["2023JJ40946, 2024JJ2093"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Changsha Natural Science Foundation","award":["kq2208377"],"award-info":[{"award-number":["kq2208377"]}]},{"name":"Youth Science Foundation of Xiangya Hospital","award":["2022Q20"],"award-info":[{"award-number":["2022Q20"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13698-9","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:22:19Z","timestamp":1739960539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Senescence-specific molecular subtypes stratify the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Luzhe","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiezheng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingshan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongbing","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"1","key":"13698_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"13698_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","volume":"17","author":"JJ Meeks","year":"2020","unstructured":"Meeks JJ, Al-Ahmadie H, Faltas BM, Taylor JA 3rd, Flaig TW, DeGraff DJ, et al. Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes. Nat Rev Urol. 2020;17(5):259\u201370.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"13698_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21(2):104\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"13698_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrurol.2017.179","volume":"15","author":"KM Felsenstein","year":"2017","unstructured":"Felsenstein KM, Theodorescu D. Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy. Nat Rev Urol. 2017;15(2):92\u2013111.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"13698_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell. 2017;168(4):613\u201328.","journal-title":"Cell"},{"issue":"3","key":"13698_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1464-410X.2009.09076.x","volume":"105","author":"SF Shariat","year":"2010","unstructured":"Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2010;105(3):300\u20138.","journal-title":"BJU Int"},{"issue":"8","key":"13698_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41585-022-00611-3","volume":"19","author":"A Martin","year":"2022","unstructured":"Martin A, Woolbright BL, Umar S, Ingersoll MA, Taylor JA. Bladder cancer, inflammageing and microbiomes. Nat Rev Urol. 2022;19(8):495\u2013509.","journal-title":"Nat Rev Urol"},{"key":"13698_CR8","doi-asserted-by":"crossref","unstructured":"Li CH, Haider S, Boutros PC. Age influences on the molecular presentation of tumours. Nature Commun. 2022;13(1):208.","DOI":"10.1038\/s41467-021-27889-y"},{"key":"13698_CR9","doi-asserted-by":"crossref","unstructured":"Wang X, Langevin A-M, Houghton PJ, Zheng S. Genomic disparities between cancers in adolescent and young adults and in older adults. Nat Commun. 2022;13(1):7223.","DOI":"10.1038\/s41467-022-34959-2"},{"issue":"1","key":"13698_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cmet.2022.11.001","volume":"35","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Pietrocola F, Roiz-Valle D, Galluzzi L, Kroemer G. Meta-hallmarks of aging and cancer. Cell Metab. 2023;35(1):12\u201335.","journal-title":"Cell Metab"},{"issue":"5","key":"13698_CR11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.14336\/AD.2017.0103","volume":"8","author":"JR Aunan","year":"2017","unstructured":"Aunan JR, Cho WC, S\u00f8reide K. The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks. Aging Dis. 2017;8(5):628\u201342.","journal-title":"Aging Dis"},{"issue":"2","key":"13698_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2019","unstructured":"Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2019;20(2):89\u2013106.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"13698_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2022.09.002","volume":"9","author":"Y Gabai","year":"2023","unstructured":"Gabai Y, Assouline B, Ben-Porath I. Senescent stromal cells: roles in the tumor microenvironment. Trends in Cancer. 2023;9(1):28\u201341.","journal-title":"Trends in Cancer"},{"issue":"8","key":"13698_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","volume":"19","author":"DV Faget","year":"2019","unstructured":"Faget DV, Ren Q, Stewart SA. Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer. 2019;19(8):439\u201353.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"13698_CR15","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.7150\/ijbs.85209","volume":"19","author":"C Gui","year":"2023","unstructured":"Gui C, Wei J, Mo C, Liang Y, Cen J, Chen Y, Wang D, Luo J. Therapeutic implications for localized prostate cancer by multiomics analyses of the ageing microenvironment landscape. Int J Biol Sci. 2023;19(12):3951\u201369.","journal-title":"Int J Biol Sci"},{"key":"13698_CR16","doi-asserted-by":"crossref","unstructured":"Liu S, Meng Y, Zhang Y, Qiu L, Wan X, Yang X, Zhang Y, Liu X, Wen L, Lei X, et al. Integrative analysis of senescence-related genes identifies robust prognostic clusters with distinct features in hepatocellular carcinoma. J Adv Res. 2024;04:007.","DOI":"10.1016\/j.jare.2024.04.007"},{"issue":"11","key":"13698_CR17","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s43587-024-00704-1","volume":"4","author":"S Meguro","year":"2024","unstructured":"Meguro S, Johmura Y, Wang TW, Kawakami S, Tanimoto S, Omori S, Okamura YT, Hoshi S, Kayama E, Yamaguchi K, et al. Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretion. Nature aging. 2024;4(11):1582\u201397.","journal-title":"Nature aging"},{"issue":"1","key":"13698_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/1078-0432.CCR-20-2488","volume":"27","author":"X Sheng","year":"2021","unstructured":"Sheng X, Yan X, Wang L, Shi Y, Yao X, Luo H, et al. Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-targeting antibody-drug conjugate, in patients with locally advanced or metastatic urothelial carcinoma. Clin Cancer Res. 2021;27(1):43\u201351.","journal-title":"Clin Cancer Res"},{"issue":"25","key":"13698_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300110","volume":"10","author":"H Li","year":"2023","unstructured":"Li H, Chen J, Li Z, Chen M, Ou Z, Mo M, et al. S100A5 Attenuates Efficiency of Anti-PD-L1\/PD-1 Immunotherapy by Inhibiting CD8(+) T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma. Adv Sci (Weinh). 2023;10(25): e2300110.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"13698_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12916-021-02163-6","volume":"19","author":"J Hu","year":"2021","unstructured":"Hu J, Othmane B, Yu A, Li H, Cai Z, Chen X, et al. 5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer. BMC Med. 2021;19(1):289.","journal-title":"BMC Med"},{"issue":"8","key":"13698_CR21","doi-asserted-by":"publisher","first-page":"e2207155","DOI":"10.1002\/advs.202207155","volume":"10","author":"Z Cai","year":"2023","unstructured":"Cai Z, Chen J, Yu Z, Li H, Liu Z, Deng D, et al. BCAT2 Shapes a Noninflamed Tumor Microenvironment and Induces Resistance to Anti-PD-1\/PD-L1 Immunotherapy by Negatively Regulating Proinflammatory Chemokines and Anticancer Immunity. Adv Sci (Weinh). 2023;10(8):e2207155.","journal-title":"Adv Sci (Weinh)"},{"key":"13698_CR22","doi-asserted-by":"publisher","first-page":"791924","DOI":"10.3389\/fimmu.2021.791924","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu Z, Qi T, Li X, Yao Y, Othmane B, Chen J, et al. A Novel TGF-\u03b2 risk score predicts the clinical outcomes and tumour microenvironment phenotypes in bladder cancer. Front Immunol. 2021;12:791924.","journal-title":"Front Immunol"},{"key":"13698_CR23","doi-asserted-by":"crossref","unstructured":"Yu A, Hu J, Fu L, Huang G, Deng D, Zhang M, et al. Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8(+) T cell infiltration and functional transition. J Immunother Cancer. 2023;11(10):e007230.","DOI":"10.1136\/jitc-2023-007230"},{"issue":"7","key":"13698_CR24","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.7150\/thno.53649","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J, Yu A, Othmane B, Qiu D, Li H, Li C, et al. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Theranostics. 2021;11(7):3089\u2013108.","journal-title":"Theranostics"},{"issue":"4","key":"13698_CR25","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.","journal-title":"Genome Biol."},{"issue":"10064","key":"13698_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","volume":"389","author":"AV Balar","year":"2017","unstructured":"Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, et al. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet. 2017;389(10064):67\u201376.","journal-title":"Lancet"},{"issue":"7693","key":"13698_CR27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"2","key":"13698_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25(2):152\u201365.","journal-title":"Cancer Cell"},{"issue":"12","key":"13698_CR29","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","volume":"18","author":"G Sj\u00f6dahl","year":"2012","unstructured":"Sj\u00f6dahl G, Lauss M, L\u00f6vgren K, Chebil G, Gudjonsson S, Veerla S, et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res. 2012;18(12):3377\u201386.","journal-title":"Clin Cancer Res"},{"issue":"1\u20133","key":"13698_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.febslet.2004.07.006","volume":"571","author":"JP de Magalh\u00e3es","year":"2004","unstructured":"de Magalh\u00e3es JP, Toussaint O. GenAge: a genomic and proteomic network map of human ageing. FEBS Lett. 2004;571(1\u20133):243\u20137.","journal-title":"FEBS Lett"},{"key":"13698_CR31","doi-asserted-by":"crossref","unstructured":"Rafikova E, Nemirovich-Danchenko N, Ogmen A, Parfenenkova A, Velikanova A, Tikhonov S, et al. Open Genes-a new comprehensive database of human genes associated with aging and longevity. Nucleic Acids Res. 2023;52(D1):D950\u201362.","DOI":"10.1093\/nar\/gkad712"},{"issue":"1","key":"13698_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13059-020-01990-9","volume":"21","author":"RA Avelar","year":"2020","unstructured":"Avelar RA, Ortega JG, Tacutu R, Tyler EJ, Bennett D, Binetti P, et al. A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol. 2020;21(1):91.","journal-title":"Genome Biol"},{"issue":"D1","key":"13698_CR33","doi-asserted-by":"publisher","first-page":"D805","DOI":"10.1093\/nar\/gkac847","volume":"51","author":"K Huang","year":"2023","unstructured":"Huang K, Gong H, Guan J, Zhang L, Hu C, Zhao W, et al. AgeAnno: a knowledgebase of single-cell annotation of aging in human. Nucleic Acids Res. 2023;51(D1):D805\u201315.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"13698_CR34","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul D, Kosinsky RL, Atkinson EJ, Doolittle ML, Zhang X, LeBrasseur NK, et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat Commun. 2022;13(1):4827.","journal-title":"Nat Commun"},{"issue":"4","key":"13698_CR35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","volume":"174","author":"AG Robertson","year":"2018","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, et al. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2018;174(4):1033.","journal-title":"Cell"},{"key":"13698_CR36","doi-asserted-by":"crossref","unstructured":"Rebouissou S, Bernard-Pierrot I, de Reyni\u00e8s A, Lepage ML, Krucker C, Chapeaublanc E, et al. EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype. Sci Transl Med. 2014;6(244):244ra91.","DOI":"10.1126\/scitranslmed.3008970"},{"issue":"8","key":"13698_CR37","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer JS, Hoadley KA, Chism DD, Fan C, Tiganelli CJ, Wobker SE, et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci U S A. 2014;111(8):3110\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"13698_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/djx243","volume":"110","author":"Q Mo","year":"2018","unstructured":"Mo Q, Nikolos F, Chen F, Tramel Z, Lee YC, Hayashi K, et al. Prognostic power of a tumor differentiation gene signature for bladder urothelial carcinomas. J Natl Cancer Inst. 2018;110(5):448\u201359.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"13698_CR39","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reynies A, Allory Y, Sjodahl G, Robertson AG, Seiler R, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. 2020;77(4):420\u201333.","journal-title":"Eur Urol"},{"issue":"23","key":"13698_CR40","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu L, Deng C, Pang B, Zhang X, Liu W, Liao G, et al. TIP: A web server for resolving tumor immunophenotype profiling. Can Res. 2018;78(23):6575\u201380.","journal-title":"Can Res"},{"issue":"4","key":"13698_CR41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.euf.2019.10.016","volume":"6","author":"G Motterle","year":"2020","unstructured":"Motterle G, Andrews JR, Morlacco A, Karnes RJ. Predicting response to neoadjuvant chemotherapy in bladder cancer. Eur Urol Focus. 2020;6(4):642\u20139.","journal-title":"Eur Urol Focus"},{"issue":"2","key":"13698_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1470-2045(21)00660-4","volume":"23","author":"AO Siefker-Radtke","year":"2022","unstructured":"Siefker-Radtke AO, Necchi A, Park SH, Garc\u00eda-Donas J, Huddart RA, Burgess EF, et al. Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. Lancet Oncol. 2022;23(2):248\u201358.","journal-title":"Lancet Oncol"},{"issue":"4","key":"13698_CR43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJMoa1817323","volume":"381","author":"Y Loriot","year":"2019","unstructured":"Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, et al. Erdafitinib in locally advanced or metastatic urothelial carcinoma. N Engl J Med. 2019;381(4):338\u201348.","journal-title":"N Engl J Med"},{"issue":"21","key":"13698_CR44","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMoa2308849","volume":"389","author":"Y Loriot","year":"2023","unstructured":"Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, et al. Erdafitinib or chemotherapy in advanced or metastatic urothelial carcinoma. N Engl J Med. 2023;389(21):1961\u201371.","journal-title":"N Engl J Med"},{"issue":"8","key":"13698_CR45","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, et al. IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127(8):2930\u201340.","journal-title":"J Clin Invest"},{"issue":"41","key":"13698_CR46","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1038\/s41388-022-02456-x","volume":"41","author":"W Liu","year":"2022","unstructured":"Liu W, Shen D, Ju L, Zhang R, Du W, Jin W, et al. MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3. Oncogene. 2022;41(41):4606\u201317.","journal-title":"Oncogene"},{"issue":"2","key":"13698_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41416-022-01794-7","volume":"127","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Zhang Z, Chen H, Bao W, Kuang X, Zhou P, et al. SBSN drives bladder cancer metastasis via EGFR\/SRC\/STAT3 signalling. Br J Cancer. 2022;127(2):211\u201322.","journal-title":"Br J Cancer"},{"issue":"4","key":"13698_CR48","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1096\/fj.201903176R","volume":"34","author":"C Wang","year":"2020","unstructured":"Wang C, Liu Q, Huang M, Zhou Q, Zhang X, Zhang J, et al. Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer. Faseb j. 2020;34(4):5754\u201366.","journal-title":"Faseb j"},{"key":"13698_CR49","doi-asserted-by":"publisher","first-page":"860663","DOI":"10.3389\/fsurg.2022.860663","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Qi T, Long Y, Li X, Yao Y, Wu Q, et al. GATA3 Predicts the tumor microenvironment phenotypes and molecular subtypes for bladder carcinoma. Front Surg. 2022;9:860663.","journal-title":"Front Surg"},{"issue":"6","key":"13698_CR50","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00345-015-1698-x","volume":"34","author":"HC Yeh","year":"2016","unstructured":"Yeh HC, Huang CN, Li CC, Chang LL, Lin HH, Ke HL, et al. Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer. World J Urol. 2016;34(6):835\u201346.","journal-title":"World J Urol"},{"issue":"11","key":"13698_CR51","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-22-2485","volume":"83","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li Y, Zhou L, Zhou H, Ye L, Ou T, et al. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response. Cancer Res. 2023;83(11):1834\u201350.","journal-title":"Cancer Res"},{"issue":"7","key":"13698_CR52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41419-023-05970-2","volume":"14","author":"H Chen","year":"2023","unstructured":"Chen H, Yang W, Li Y, Ji Z. PLAGL2 promotes bladder cancer progression via RACGAP1\/RhoA GTPase\/YAP1 signaling. Cell Death Dis. 2023;14(7):433.","journal-title":"Cell Death Dis"},{"issue":"7","key":"13698_CR53","first-page":"4397","volume":"11","author":"S Lu","year":"2019","unstructured":"Lu S, Guo M, Fan Z, Chen Y, Shi X, Gu C, et al. Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer. Am J Transl Res. 2019;11(7):4397\u2013410.","journal-title":"Am J Transl Res"},{"issue":"4","key":"13698_CR54","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, et al. Cellular Senescence: Defining a Path Forward. Cell. 2019;179(4):813\u201327.","journal-title":"Cell"},{"issue":"9","key":"13698_CR55","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/s41556-023-01214-9","volume":"25","author":"BB Grigorash","year":"2023","unstructured":"Grigorash BB, van Essen D, Liang G, Grosse L, Emelyanov A, Kang Z, et al. p16High senescence restricts cellular plasticity during somatic cell reprogramming. Nat Cell Biol. 2023;25(9):1265\u201378.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"13698_CR56","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181(3):362\u201374.","journal-title":"Br J Pharmacol"},{"key":"13698_CR57","doi-asserted-by":"crossref","unstructured":"Giusti R, Mazzotta M, Filetti M, Marinelli D, Di Napoli A, Scarpino S, et al. CDKN2A\/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach. Am Soc Clin Oncol; 2019;37(15).","DOI":"10.1200\/JCO.2019.37.15_suppl.e20628"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13698-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13698-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:22:34Z","timestamp":1739960554000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13698-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13698"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13698-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, the study plan was approved by the ethics committee of Xiangya Hospital, Central South University. All the specimens were collected complying with informed consent right.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}